Biological Mechanisms of Major Depressive Disorder: Exploring Neural Circuits and Neurotransmitter Systems in Diagnosis and Treatment

Major Depressive Disorder (MDD) is a severe mental illness characterized by persistent low mood, impaired cognitive function, and disrupted emotional regulation. The development and maintenance of MDD involve complex interactions between neural circuits and neurotransmitter systems. This paper provides a comprehensive review of the biological underpinnings of MDD, focusing on how dysfunctions in neurotransmitter systems and neural circuits contribute to the disorder. Key neurotransmitters, such as serotonin, norepinephrine, dopamine, glutamate, and GABA, and their associated neural circuits, including the amygdala, prefrontal cortex, hippocampus, and hypothalamic-pituitary-adrenal axis, are examined for their roles in the pathophysiology of MDD. The research also explores recent advances in treatment approaches targeting these systems, including pharmacological interventions like SSRIs, SNRIs, and ketamine, as well as neuromodulation techniques such as Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy (ECT). Through an extensive literature review, this study highlights the importance of understanding the biological mechanisms underlying MDD to develop more effective therapeutic strategies. By identifying and addressing these mechanisms, the research aims to improve treatment outcomes and enhance the quality of life for individuals suffering from this debilitating condition. Key words: Major Depressive Disorder (MDD), Neural circuits, Neurotransmitter systems, Serotonin, Norepinephrine, Dopamine, Glutamate, GABA, Neuroplasticity, Pharmacological treatments, Transcranial Magnetic Stimulation (TMS), Electroconvulsive Therapy (ECT), Pathophysiology of depression, Neuromodulation, Biological mechanisms of depression